Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

SalMar ASA (SALM)

Verdict history · SALM

Every call Verdix has made on SALM.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

See methodology for how verdicts are produced. Full track record →

The panel’s case against SALM — and where they disagree.

SellHIGH confidence

The case against outweighs the case for at today's price.

OSL · Consumer Staples · 2026-08-18 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Sell

HIGH confidence

Why

SalMar trades at 517.5 NOK with a panel split of five Bearish voices and one Neutral. The debate hangs on whether a forward P/E of 16.6× backed by 50%+ EPS growth can overcome a 22.1B NOK debt load, thinning interest coverage, and a confirmed Stage 4 downtrend — or whether those cheap-looking multiples are a value trap built on growth assumptions already sliding lower. The lone neutral voice passes entirely, waiting for a pullback to the 410–440 range before even considering a position.

Level to watch

Key support 516.38

−0.2% from 517.5

Next catalyst

Trigger to pause the bear case: A weekly close above the EMA20 at approximately 528 NOK would be the first step toward breaking the Stage 4 downtrend and would pause the bear case across all five Bearish voices.

The panel's take

Verdict: SELL · Conviction: HIGH · Last price: 517.5

Panel: 0 Bullish · 1 Neutral · 5 Bearish → SELL

Five of six voices are Bearish, the Neutral voice (The Asymmetric Bargainer) explicitly passes rather than buys, and no voice is Bullish. The verdict is SELL because every voice that reached a directional conclusion — whether on value, technicals, leverage, sentiment, or earnings quality — landed on the same side. The Asymmetric Bargainer's Neutral stance is a refusal to buy at this price, not a defence of the stock; the stated position is a flat pass — “there are better fish to fry.” The only daylight between the five Bearish voices and the one Neutral voice is that The Asymmetric Bargainer would buy on a pullback to 410-440, while the outright bears see fair value nearer 470–480 and want a trend change before even considering a position.

Key levels

Key levels · SALM

NOK · as of 2026-08-18
Analyst consensus 611
R3540
+4.3%
R2528
+2.0%
R1520
+0.5%
S1516.38
−0.2%
S2486
−6.1%
S3448
−13.4%
NOW
517.5

Analyst consensus target 611 NOK · range 594628

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key resistance at 520-528 is the lost horizontal support (520) now flipped overhead along with the weekly EMA20 (528) — both sit just above price and define the Stage 4 grip. Further overhead, the SMA40 at 557 and the volume POC at 565 form a historical accumulation zone that price would need to reclaim for any serious recovery. Key support is the weekly 61.8% Fibonacci at 516.38, which price is already kissing; a break there opens the path to the 486 confluence zone (weekly 78.6% and monthly 61.8%), the next major support. The analyst consensus target of 594-628 sits well above resistance, reflecting the gap between what analysts model and what the market is currently paying.

What legendary investors think

We ran SalMar ASA past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
0
Bullish
1
Neutral
🔴
5
Bearish
The Forensic SkepticContrarian/Forensic🔴 BearishLow

Signal: The spread between trailing P/E of 34–35× and forward P/E of 16.6× exposes the entire investment case as dependent on 54% EPS growth that is already being revised downward — FY2026 consensus fell from 33.6 to 31.11 in 90 days — and beneath that growth premium sits a leveraged commodity producer with 9.76% ROE, 3.72× net debt/EBITDA, and interest coverage of just 2.85×. Conviction: Conviction strengthens because three independent signals align: Nordea's downgrade to Sell is a material adverse indicator, the technical structure is an unambiguous Stage 4 across both monthly and weekly timeframes, and the earnings revisions trajectory points in only one direction — but without tangible book value or salmon spot price data, the precise magnitude of downside remains uncertain.

The Intrinsic-Value ModelerValuation/DCF🔴 BearishLow

Signal: A base-case DCF built on 10% revenue growth fading to 4%, operating margins compressing to 12% from today's 15%, and a 9.5% cost of capital reflecting the 3.7× leveraged balance sheet produces a fair value near 470 NOK, roughly 9% below the current price of 517.5 — meaning the market is already pricing in the growth story without discounting the financial risk. Conviction: Conviction is muted because the cost of capital is an estimate rather than a precise calculation — Norway's risk-free rate, the equity risk premium, and a reliable beta are all absent from the evidence — so the DCF output is a directional signal, not a pinpoint.

The GARP OperatorGrowth (GARP)🔴 BearishLow

Signal: The PEG of 0.84 vanishes when the unsustainable 54% EPS growth assumption is replaced with a more realistic 10–15% long-term rate, pushing the PEG to 1.1–1.7 and revealing a cyclical stock trading at a forward multiple that only looks cheap because the growth input is heroic — this is exactly the trap GARP Operator warned about when earnings are commodity-driven, not moat-driven. Conviction: The conviction gets a boost from a clean alignment: the balance sheet is exactly the kind GARP Operator hates (22B NOK net debt, interest coverage barely 3×), the technical picture is uniformly bearish, and analyst downgrades are rolling in — three hard facts, no single point of failure.

The Asymmetric BargainerContrarian/Deep Value NeutralLow

Signal: The Dhandho test fails on the second question — downside is not limited: 22.1B NOK in net debt with 2.85× interest coverage means a salmon-price collapse could inflict real, possibly severe, loss, so this is not a 'heads I win, tails I don't lose much' situation. Conviction: A clear pass is held back by the absence of any insider buying in the last 90 days and zero superinvestor 13F filings — when no one with skin in the game is stepping up at these prices, the asymmetric case stays theoretical.

The Macro OpportunistMacro/Timing🔴 BearishMed

Signal: The weekly chart shows a textbook Stage 4 downtrend — price below a fully bearish EMA stack (20<50<200), MACD negative and widening on the monthly, and volume confirming apathy rather than accumulation — with the 61.8% Fibonacci at 516 barely holding as the next major support at 486 represents a clear 6% downside target. Conviction: What pushes conviction higher is the rare alignment of technicals, fundamentals, and sentiment: the forward P/E story is a promise, not a fact, the 10Y yield at 4.7% punishes a 3.72× leveraged balance sheet, and Nordea's downgrade to Sell is a real institutional signal — these are not dependent on a single assumption.

The Margin-of-Safety HunterValue/Quantitative🔴 BearishLow

Signal: The stock fails every quantitative criterion in the defensive checklist — current ratio 1.52 versus the required 2.0, P/E 34–35× versus the 15× limit, P/B 3.35–3.92× versus 1.5× — and trades at 2.44 times the calculated Margin-of-Safety Hunter Number of approximately 212 NOK, offering zero margin of safety by any measure. Conviction: Conviction is constrained to low confidence because critical evidence is missing — no 10-year earnings history, no confirmed TTM EPS, no dividend record — so while the direction is clear, the precision of the quantitative assessment is thinner than I would like.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All six archetypes agree that the current price of 517.5 NOK clears none of their bars — whether because it sits above intrinsic value, leaves no margin of safety, or lacks the asymmetric payoff profile each framework requires.
  • Every voice that addresses the balance sheet calls out the 22.1B NOK net debt and thin interest coverage (2.85–3.0×) as the single largest risk factor.
  • The Stage 4 downtrend is unanimously acknowledged — even The Asymmetric Bargainer, who is the lone Neutral voice, cites it as one reason for passing.
  • No archetype finds insider buying or superinvestor activity that would signal conviction from informed participants.

The real debate

  • The Intrinsic-Value Modeler sees fair value near 470 NOK, implying the stock is modestly overvalued and the short case is measured. The Margin-of-Safety Hunter calculates the Margin-of-Safety Hunter Number of 212 NOK, which would require a 59% decline just to reach the threshold for consideration — a far more severe verdict that reflects a permanent-capital-loss framework versus a DCF framework.
  • The Asymmetric Bargainer would buy on a pullback to 410–440 NOK because at that level the forward earnings story finally meets their margin-of-safety requirement. The GARP Operator, by contrast, would not buy even there — that lens needs the debt reduced and the trend to reverse first, because a cheap cyclical can stay cheap for years if the balance sheet remains strained.
  • The Forensic Skeptic and The Macro Opportunist both see the forward P/E of 16.6× as a mirage built on 50%+ EPS growth that is already eroding, while The Asymmetric Bargainer treats that forward multiple as the one genuinely interesting number in the whole setup — they just won't pay today's price for it.

The question it comes down to: Does the forward earnings story — 16.6× P/E, 50%+ EPS growth, record biology — represent a genuine discount that will re-rate once Q2 2026 delivers, or is it a value trap where high debt and commodity exposure will punish any earnings stumble before the growth ever materializes?

The bottom line

  • Trigger to pause the bear case: A weekly close above the EMA20 at approximately 528 NOK would be the first step toward breaking the Stage 4 downtrend and would pause the bear case across all five Bearish voices.
  • Fundamental catalyst to watch: Q2 2026 earnings (due late August 2026) with an EPS beat versus the 7.39 NOK consensus, paired with an upward revision to FY2026 guidance and net debt reduced below 2.5× EBITDA, would force a fundamental reassessment.
  • Risk to monitor: A break below the 486 NOK confluence level (weekly 78.6% Fibonacci and monthly 61.8% Fibonacci) with rising volume would open the path to the 52-week low near 448 and likely trigger forced selling from leverage-conscious holders.
  • Sentiment signal: A new insider purchase of meaningful size, or a disclosed position from a known value investor, would challenge the current consensus that no one with skin in the game sees value here.

contact@verdixhq.com · Published 2026-08-18 · Prices as of 2026-08-18 · Time horizon: 3–12 months · No position held in SALM.OL by the producer or its personnel at the time of publication. No compensation received from SalMar ASA or any party with an interest in the security. · SALM verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of SALM's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.